PET adapted treatment improves outcome of patients with stages I/II Hodgkin Lymphoma
2015-07-15
(Press-News.org) Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
Dr. John Raemaekers of the Radboud University Medical Center Nijmegen and the Rijnstate Hospital Arnhem, The Netherlands, and EORTC principal study coordinator on behalf of the EORTC/LYSA/FIL Intergroup H10 team says, "Even though the prognosis for patients with stage I/II HL is excellent if they are treated with the standard regimen of chemotherapy combined with radiotherapy, tumor control could still be improved for specific subgroups of patients, and late toxicity could be reduced for others. This trial, therefore, addressed two questions. First, can the outcome for early FDG-PET-positive patients with stages I/II Hodgkin lymphoma be improved by administering early intensification of chemotherapy? Second, can involved-node radiotherapy be omitted from the standard combined modality treatment in early PET-negative patients?"
This intergroup trial demonstrated that patients with stage I/II Hodgkin Lymphoma, who are still FDG-PET positive after two cycles of ABVD chemotherapy, significantly benefit in terms of progression free survival from intensification to BEACOPPesc chemotherapy followed by involved-node radiotherapy compared to patients who continue standard ABVD chemotherapy followed by involved-node radiotherapy (5yr progression-free survival rates 91% versus 77%, HR=0.42, 95%CI:0.23 to 0.74, p=0.002, with a difference of 13%, 95%CI:5% to 21%). The analysis of the early PET negative group confirmed the conclusions of the previously published interim analysis. We could not demonstrate that treatment with chemotherapy only is non-inferior to the standard combined modality treatment in terms of progression free survival.
The Intergroup EORTC/LYSA/FIL H10 20051 trial included 1950 patients aged 15-70 years with previously untreated stage I/II supradiaphragmatic, classical Hodgkin Lymphoma. This trial was conducted at 158 sites located in eight countries: France, Italy, The Netherlands, Belgium, Denmark, Croatia, Slovakia and Switzerland. Support for this trial came from Fondation belge contre le Cancer (Belgium); Dutch Cancer Society (the Netherlands); Institut National du Cancer, Fondation Contre le Cancer, Assistance Publique Hôpitaux Paris, and Société Française de Medecine Nucleaire et Imagerie Moleculaire (France); Associazone Angela Serra (Italy); and Chugai Pharmaceutical (Japan).
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-15
HOUSTON - (July 15, 2015) - Three-dimensional structures of boron nitride might be the right stuff to keep small electronics cool, according to scientists at Rice University.
Rice researchers Rouzbeh Shahsavari and Navid Sakhavand have completed the first theoretical analysis of how 3-D boron nitride might be used as a tunable material to control heat flow in such devices.
Their work appears this month in the American Chemical Society journal Applied Materials and Interfaces.
In its two-dimensional form, hexagonal boron nitride (h-BN), aka white graphene, looks ...
2015-07-15
A University of Toronto research team has discovered new details about a key gene involved in ALS, perhaps humanity's most puzzling, intractable disease.
In this fatal disorder with no effective treatment options, scientists (including members of U of T) achieved a major breakthrough in 2011 when they discovered mutations in the gene C9orf72, as the most frequent genetic cause of ALS and frontotemporal dementia. But little was known about how this gene and its related protein worked in the cell.
To solve this problem, Professor Janice Robertson and her team at the ...
2015-07-15
Sapphirina, or sea sapphire, has been called "the most beautiful animal you've never seen," and it could be one of the most magical. Some of the tiny, little-known copepods appear to flash in and out of brilliantly colored blue, violet or red existence. Now scientists are figuring out the trick to their hues and their invisibility. The findings appear in the Journal of the American Chemical Society and could inspire the next generation of optical technologies.
Copepods are tiny aquatic crustaceans that live in both fresh and salt water. Some males of the ocean-dwelling ...
2015-07-15
Five years ago this week, engineers stopped the Deepwater Horizon (DWH) oil spill -- the largest one in U.S. history, easily displacing the Exxon Valdez spill from the top spot. Now, Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, takes a look at the lessons scientists are learning from these accidents to improve clean-up efforts and, perhaps, prevent spills altogether.
C&EN Senior Editor Jyllian Kemsley explains that although both spills were caused by human error, they each posed unique challenges. When the tanker Exxon ...
2015-07-15
"No swimming" signs have already popped up this summer along coastlines where fecal bacteria have invaded otherwise inviting waters. Some vacationers ignore the signs while others resign themselves to tanning and playing on the beach. But should those avoiding the water be wary of the sand, too? New research in the ACS journal Environmental Science & Technology investigates reasons why the answer could be "yes."
Sewage-contaminated coastal waters can lead to stomach aches, diarrhea and rashes for those who accidentally swallow harmful microbes or come into contact with ...
2015-07-15
A mixture of bitumen and gasoline-like solvents known as dilbit that flows through Prairie pipelines can seriously harm fish populations, according to research out of Queen's University and the Royal Military College of Canada.
At toxic concentrations, effects of dilbit on exposed fish included deformities and clear signs of genetic and physiological stress at hatch, plus abnormal or uninflated swim bladders, an internal gas-filled organ that allows fish to control their buoyancy. Exposure to dilbit reduces their rate of survival by impairing their ability to feed and ...
2015-07-15
New research conducted at the University of Kansas Medical Center indicates that older adults can improve brain function by raising their fitness level.
Jeffrey Burns, M.D., professor of neurology and co-director of the KU Alzheimer's Disease Center, led a six-month trial conducted with healthy adults ages 65 and older who showed no signs of cognitive decline. The results of the study were published on July 9 in the journal PLOS ONE.
The randomized controlled trial attempted to determine the ideal amount of exercise necessary to achieve benefits to the brain. Trial ...
2015-07-15
In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer. Their report appears in the ACS journal Analytical Chemistry.
Many modern diagnostic techniques involve analyzing DNA in a patient's blood sample. ...
2015-07-15
WASHINGTON (July 15, 2015) -- GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology. This research, published in the Journal of Investigative Dermatology, identified that the nanoparticles were effective at killing Proprionobacterium acnes, the gram positive bacteria associated with acne, and even more importantly, they inhibited the damaging inflammation that result in the large, painful lesions associated with inflammatory acne.
"Our understanding ...
2015-07-15
Philadelphia, PA, July 15, 2015 - Peripartum cardiomyopathy (PPCM) is a rare disorder characterized by weakened pumping of the heart, or "left ventricular dysfunction," which results in otherwise healthy pregnant women experiencing heart failure shortly before or up to five months after they deliver healthy babies. Despite the seriousness of this condition, a new study published in the Canadian Journal of Cardiology revealed that no significant research has been undertaken to explore how to prevent or treat this disorder. In fact, only three studies of possible treatments ...
LAST 30 PRESS RELEASES:
[Press-News.org] PET adapted treatment improves outcome of patients with stages I/II Hodgkin Lymphoma
